The expression of TNFRSF4 mRNA in AML patients was significantly higher compared with HDs (p = 0.0377) and MDS (EB-1, 2; p = 0.0017; Fig. 2h) patients respectively. Here, TNFRSF4 is linked to acute myeloid leukemia.